<!-- docs/marketing/investors/vc-firms/red-cell-partners.md -->

# Red Cell Partners - BuildOS Investor Profile

**Last Updated**: February 2026
**Source**: DC-Based Elite VCs List (LinkedIn)

## Fund Overview

- **Total AUM**: ~$500M (firm + portfolio companies)
- **Founded**: 2020
- **Headquarters**: McLean, Virginia (DC Metro)
- **Structure**: Venture Studio (builds, launches, scales companies)
- **Fund I**: $91M (2023)
- **Geographic Focus**: United States
- **Sector Focus**: Healthcare, Cybersecurity, National Security

## Investment Thesis

**"Impact Through Innovation"**

Red Cell Partners is a venture studio that builds, launches, and scales technology-led companies across healthcare, cybersecurity, and national security. Unlike traditional VCs, they incubate companies internally (13 of ~20 portfolio companies were built in-house) and bring operational expertise from day one.

## Key Team

### Grant Verstandig - Founder, Chairman & CEO

- Dropped out of Brown University
- Founded Rally Health in 2010 (consumer-centric digital health)
- Sold Rally Health to UnitedHealth Group in 2017 (one of largest digital health exits ever)
- Named **2025 Tech Titan** by Washingtonian
- Aspen Digital Global Cybersecurity Group member
- Proud supporter of Greater Washington, D.C., area hospitals

### Grant Verstandig's Current Board Roles:

- **Epirus** - Board Member
- **Claros** - Executive Chairman
- **Andesite AI** - Executive Chairman and Board Member
- **DEFCON AI** - Chairman
- **TARA Mind** - Executive Chairman
- **Eyris** - Co-Founder
- **Zephyr AI** - Chairman
- **Trase Systems** - CEO and Co-Founder

### July 2025: Michael Kilberry Joins as CPTO

Former head of product for Google and Amazon joined Red Cell as Chief Product and Technology Officer, signaling increased focus on product development and scaling.

## Portfolio Companies

### Flagship Portfolio (2024-2025):

| Company   | Sector            | Funding                            | Status                                       |
| --------- | ----------------- | ---------------------------------- | -------------------------------------------- |
| Zephyr AI | Healthcare AI     | $111M Series A (2024)              | AI-powered healthcare platform               |
| DEFCON AI | Defense Tech      | $44M Seed (2024) - led by Bessemer | One of largest defense-tech seed rounds ever |
| Epirus    | Defense Tech      | $500M+ total raised                | High-power microwave defense systems         |
| Valinor   | National Security | Active                             | Defense technology                           |
| Trase     | Enterprise AI     | $10.5M pre-seed (emerged Nov 2025) | Last-mile AI adoption platform               |
| Andesite  | Cybersecurity     | Co-developed with General Catalyst | Cyber company                                |
| Crux      | Data/Analytics    | $6.5M pre-seed from Red Cell       | Data infrastructure                          |

### Recent Milestones (2024-2025):

- **DEFCON AI**: Delivered ARTIVâ„¢ decision-support tool to U.S. Air Force (2024); $44M seed round led by Bessemer (one of largest defense-tech seed rounds ever)
- **Zephyr AI**: $111M Series A closed (2024); mission to transform drug discovery and precision medicine
- **Trase Systems**: Grant Verstandig is CEO; AI agent platform that has **repeatedly topped the GAIA leaderboard** for general AI assistants, outperforming agents from Meta, Microsoft, and Google
- **Trase**: Hired former leader of Amazon's Bedrock and Sagemaker ($10.5M pre-seed)
- **UMass Memorial Health**: Partnership announced June 2025
- **Michael Kilberry**: Former Google/Amazon product exec joined as CPTO (July 2025)

### Portfolio Scale:

- **19 companies** in 4 years
- **13 built internally** (from ground up)
- **~$240M combined funding** raised by portfolio companies (Q1 2025)
- **$425M** venture studio portfolio value

### DEFCON AI Deep Dive:

- Founded by Red Cell co-founders Grant Verstandig and Yisroel Brumer, plus retired U.S. Air Force General Paul Selva (CSO)
- Cloud-based software simulates war scenarios for military preparation
- Identifies vulnerabilities in enemy forces, suggests responses
- Board includes Christopher Wan (Bessemer) and Dr. Ray O. Johnson (former Lockheed Martin CTO)

## Why Red Cell Partners Could Be Strategic for BuildOS

### Potential Alignment:

1. **Venture Studio Model**: Hands-on operational support, not just capital
2. **National Security DNA**: Aligns with Anna's USMC background
3. **Healthcare AI Expertise**: Zephyr AI shows understanding of AI-native applications
4. **Operational Excellence**: Military-grade discipline in company building
5. **DC Network**: Deep government and defense contractor relationships

### Potential Concerns:

- **Venture Studio Focus**: May prefer to build companies internally vs. invest externally
- **Sector Mismatch**: Primary focus on healthcare/cyber/defense, not productivity tools
- **Stage**: May be later-stage focused given company-building model

## Approach Strategy

### Optimal Positioning:

1. **Veteran Connection**: Lead with Anna's USMC background and military discipline
2. **Operational AI**: Position BuildOS as AI-native operational excellence tool
3. **Government Adjacent**: Explore defense contractor/government worker use cases
4. **Productivity for High-Stakes**: "BuildOS for mission-critical work"

### Key Messages:

- "Military-grade productivity system built by a Marine veteran"
- "AI-native operational excellence for high-stakes environments"
- "The operating system for systematic thinking under pressure"

### What to Avoid:

- Positioning as pure consumer/ADHD play without broader market potential
- Ignoring their preference for internal company building
- Not highlighting defense/government market applicability

## Contact Information

- **Website**: [redcellpartners.com](https://www.redcellpartners.com/)
- **Primary Contact**: Grant Verstandig (Founder, Chairman & CEO)
- **LinkedIn**: [Red Cell Partners](https://www.linkedin.com/company/red-cell-partners)

### Warm Introduction Paths:

1. **Bessemer Venture Partners** - Co-invested in DEFCON AI
2. **General Catalyst** - Co-developed Andesite
3. **Defense Tech Community** - DC defense tech ecosystem
4. **Veteran Networks** - Military veteran founder communities

## Investment Terms (Estimated)

- **Typical Structure**: Equity investment + operational support
- **Check Size**: Varies (venture studio model)
- **Board Involvement**: High - hands-on company building approach
- **Timeline**: Longer engagement given studio model

## Summary Score: ðŸŸ¡ **Medium Priority - Strategic Value**

Red Cell Partners is impressive: $425M portfolio, 19 companies in 4 years, and **Trase Systems (Grant Verstandig as CEO) has topped the GAIA leaderboard for general AI assistants**, outperforming Meta, Microsoft, and Google. However, their venture studio model means they typically build internally rather than invest externally.

**Success Probability**: Low for direct investment (venture studio builds internally)
**Strategic Value**: Very High for partnerships/advisory:

- Grant Verstandig's AI expertise (Trase topped GAIA benchmark)
- DC/defense network and credibility
- Healthcare AI success (Zephyr AI $111M Series A)
- Former Google/Amazon product exec (Michael Kilberry) now CPTO

**Key Insight**: Trase Systems demonstrates Grant Verstandig is building cutting-edge AI agents - there may be synergy opportunities.

**Best Approaches**:

1. **Partnership**: Explore synergy between BuildOS and Trase (both AI-native productivity)
2. **Advisory**: Leverage Grant's AI agent expertise
3. **Customer Intro**: Access to defense/healthcare portfolio companies
4. **External Investment**: Less likely given studio model, but not impossible

**Recommendation**: Don't pursue for traditional VC investment. Instead:

- Explore strategic partnership or co-development opportunities
- Seek advisory relationship with Grant Verstandig on AI agent development
- Use for government/defense market introductions

---

_Profile compiled from web research, press releases, and public statements. February 2026._
